Opioid Settlement
The Office of Drug Prevention, Treatment, and Enforcement, in partnership with the Indiana Family and Social Services Administration - Division of Mental Health and Addiction and the Indiana Department of Health, has developed a framework for how the State of Indiana plans to use the state's 35% appropriation for abatement from the National Opioid Settlement with distributors McKesson, Cardinal Health and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson. House Enrolled Act 1193, passed by the Indiana General Assembly and signed by Governor Eric J. Holcomb in March 2022, creates a 50/50 state and local split and defines the intensity metrics on how much money each locality will receive.
The State is using the Johns Hopkins Bloomberg School of Public Health's five guiding principles to ensure dollars are used most effectively:
- Spend the money to save lives
- Use evidence to guide spending
- Invest in youth prevention
- Focus on racial equity
- Develop a fair and transparent process for deciding where to spend the funds.
Documents
- Click here to view Indiana's plan for the 35% appropriated for abatement to the Indiana Family and Social Services Administration.
- Exhibit E of the national settlement document outlines the approved abatement uses.
- Click here to view distribution totals for participating subdivisions.
Reporting
According to IC 4-6-15-4, the Indiana Family and Social Services Administration (FSSA) is required to submit an annual comprehensive report of the use of all opioid settlement funds, including funds received by the local units of government, to the Indiana General Assembly by October 1. All local units of government that received funds from the National Opioid Settlement are required to report their use of funds to FSSA using a unique survey link distributed to all local units of government in August 2023. The information collected was included in a final report to the Indiana General Assembly.
View the 2023 report here. To see how each local unit of government reported their use of settlement funds, click here.
Indiana's Matching Program
As part of the National Opioid Settlement, the Indiana Family and Social Services Administration (FSSA) Division of Mental Health and Addiction (DMHA), in partnership with the Office of Governor Eric J. Holcomb, awarded a total of $19 million in one-time funding to support evidence-based prevention, treatment, recovery and harm reduction services, expand the behavioral health workforce and implement other services and initiatives across the state, to 30 local units of government, service providers, and community organizations.
DMHA received 78 proposals requesting a total of $93 million in response to the grant. Local units of government were required to provide match funds in order to qualify for funding. The services funded by these grants will reach Hoosiers in at least 28 counties.
A complete list of Opioid Settlement Match Grant recipients is available here.
Capital Expenses for Recovery Residences
The Indiana Family and Social Services Administration (FSSA) Division of Mental Health and Addiction (DMHA) awarded a total of $4.7 million in one-time funding to support capital expenditures for recovery residences in the State of Indiana. Using the National Opioid Settlement Fund allotted to the State, grants were awarded to qualified community organizations to purchase, build, renovate, or otherwise sustainably acquire a suitable structure for a DMHA-certified recovery residence.
DMHA received 44 proposals requesting a total of $25 million in response to the grant. A total of 206 beds are expected to be added as a result of the grant.
A complete list of Capital Expenses for Recovery Residences Grant recipients is available here.
Frequently Asked Questions
How much money should my community expect to receive?
The Indiana Office of the Attorney General calculates the amounts local units of governments are to receive from the settlement per the terms and conditions of the settlement and House Enrolled Act 1193. Click here to view distribution totals for participating subdivisions. Estimates for 2023 and future years include projected payments for additional settlements with Walgreens, CVS, Teva, Allergan, and Walmart. The 2023 distributions for those settlements are expected later this year.
The settlements are governed by Indiana Code ยงยง 4-6-15. Under the terms of the statute governing distribution (IC 4-6-15-4), those cities and towns receiving less than $5,000 annually in abatement funding will have their distribution sent to the county. Subdivisions that hired their own attorneys and litigated on their own will also have their attorney fees deducted from their settlement payment, which will decrease the amount they will receive. For purposes of accounting for your settlement payments, please refer to the guidelines distributed in 2022 by the State Board of Accounts (SBOA).
How do I know if my community expects to receive funding?
Over 640 Indiana towns, cities, and counties have opted into the state’s settlement with distributors McKesson, Cardinal Health, and AmerisourceBergen and manufacturer Janssen Pharmaceuticals, Inc., and its parent company Johnson & Johnson. Click here to view distribution totals for participating subdivisions.
How will funds be distributed?
House Enrolled Act 1193, passed by the Indiana General Assembly and signed by Governor Eric J. Holcomb in March 2022, creates a 50/50 state and local split and defines the intensity metrics on how much money each locality will receive. Local subdivisions received their first payments in December 2022. The State Budget Committee approved Indiana's plan for the 35% appropriated for abatement to the Indiana Family and Social Services Administration in December 2022. Funding announcements can be found here.
When should Indiana expect to receive funds?
Local subdivisions received their first payments in December 2022.
How are funds being spent?
Exhibit E of the national settlement document outlines the approved abatement uses. Indiana's plan for the 35% appropriated for abatement to the Indiana Family and Social Services Administration can be found here.
Who is the point of contact?
House Enrolled Act 1193 defines the responsibilities of involved state agencies. For questions regarding the use of Indiana's 35% appropriation for abatement, contact the Office of Drug Prevention, Treatment and Enforcement at drugpte@gov.in.gov.
What are the requirements for reporting how funds are spent?
According to IC 4-6-15-4, the Indiana Family and Social Services Administration (FSSA) is required to submit an annual comprehensive report of the use of all opioid settlement funds, including funds received by the local units of government, to the Indiana General Assembly by October 1. All local units of government that received funds from the National Opioid Settlement are required to report their use of funds to FSSA using a unique survey link distributed to all local units of government in August 2023. The information collected was included in a final report to the Indiana General Assembly.
This reporting period is now closed. View the 2023 report here.
How will Indiana be transparent?
The Office of the Governor has created a webpage at in.gov/recovery/settlement where updates will be regularly posted.
Additional Resources
- National Opioid Settlement
- Office of the Attorney General - Complex Litigation
- Division of Mental Health and Addiction - Funding Announcements
Contact Us
Questions? Contact us at drugpte@gov.in.gov.
